(Q37145154)

18 August 2017

1 reference

title

Carbonic anhydrase IX: historical and future perspectives (English)

1 reference

18 August 2017

Egbert Oosterwijk

1

1 reference

18 August 2017

language of work or name

1 reference

1 June 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

101 Suppl 4

1 reference

18 August 2017

page(s)

2-7

1 reference

Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Strict regulation of CAIX(G250/MN) by HIF-1alpha in clear cell renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

A phase I trial of vaccination of CA9-derived peptides for HLA-A24-positive patients with cytokine-refractory metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Expression of tumor-associated antigens in acute myeloid leukemia: Implications for specific immunotherapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Expression of the hypoxia marker carbonic anhydrase 9 is associated with anaplastic phenotypes in meningiomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

Carbonic anhydrases as drug targets--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2008.07641.X

10.1111/J.1464-410X.2008.07641.X

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference